Amundi Index MSCI Europe ESG Broad CTB (AMS:UCEU)
426.68
+64.09 (17.68%)
At close: Jul 4, 2025, 5:30 PM CET
17.54% (1Y)
Assets | 2.02B |
Expense Ratio | 0.33% |
PE Ratio | 16.47 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +17.54% |
Volume | 163 |
Open | 426.68 |
Previous Close | 362.59 |
Day's Range | 426.68 - 426.68 |
52-Week Low | 342.46 |
52-Week High | 427.62 |
Beta | n/a |
Holdings | 379 |
Inception Date | Mar 22, 2018 |
About UCEU
Amundi Index MSCI Europe ESG Broad CTB is an exchange traded fund launched and managed by Amundi Asset Management. It invests in the public equity markets of developed markets in Europe. The fund uses derivatives such as swaps to invest in stocks of companies operating across diversified sectors. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI Europe Index, by employing synthetic replication methodology. Amundi Index MSCI Europe ESG Broad CTB was formed on August 20, 2008 and is domiciled in Luxembourg.
Asset Class Equity
Category Total Market
Stock Exchange Euronext Amsterdam
Ticker Symbol UCEU
Provider Amundi
Index Tracked MSCI Europe ESG Broad CTB Select Index - EUR - Benchmark TR Net
Performance
UCEU had a total return of 17.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.09%.
Top 10 Holdings
19.51% of assetsName | Symbol | Weight |
---|---|---|
ASML Holding N.V. | ASML | 2.66% |
SAP SE | SAP | 2.61% |
Novartis AG | NOVN | 2.23% |
AstraZeneca PLC | AZN | 1.87% |
Roche Holding AG | ROG | 1.86% |
Novo Nordisk A/S | NOVO.B | 1.79% |
HSBC Holdings plc | HSBA | 1.76% |
Allianz SE | ALV | 1.69% |
Schneider Electric S.E. | SU | 1.55% |
Siemens Aktiengesellschaft | SIE | 1.50% |